BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Anticancer prodrugs
,
Phenobarbital
,
rs2300478
,
DNMT1
,
Angiogenesis
,
Arthritis
,
Breast
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
DNA (cytosine-5)-methyltransferase 3 alpha
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for DNA (cytosine-5)-methyltransferase 3 alpha
Explore Curated Studies Results
Literature
Most Relevant Literature
Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer.
Transcriptional and functional consequences of Oncostatin M signaling on young Dnmt3a-mutant hematop…
Single substitution in H3.3G34 alters DNMT3A recruitment to cause progressive neurodegeneration.
From molecular pathogenesis to therapy: Unraveling non-coding RNAs/DNMT3A axis in human cancers.
DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and h…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in…
Genetic Aspects of Vaginal Aging
Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581
Utility of Primary Glioblastoma Cell Lines
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ